Centrum Usług Medycznych MaxMed
- Address
- ul. Krakowska 27A, 32-700 Bochnia, Poland
Centrum Usług Medycznych MaxMed - Dermatology and Gastroenterology Research Center
Centrum Usług Medycznych MaxMed is a clinical research facility specializing in dermatological and gastrointestinal disorders. The center demonstrates particular expertise in investigating novel therapeutic approaches for chronic inflammatory conditions, with a strong focus on plaque psoriasis and atopic dermatitis. Their research portfolio includes both topical and systemic treatment modalities, as well as biologics and small molecule therapies.
- Moderate to severe plaque psoriasis: investigating oral and topical formulations including novel agents like TAK-279 and mometasone furoate cutaneous emulsion
- Atopic dermatitis: evaluating subcutaneous biologic therapies such as lunsekimig (SAR443765) for moderate-to-severe disease
- Inflammatory bowel disease: conducting extension studies for Crohn's disease treatments including oral ozanimod
The center's research program emphasizes long-term safety and efficacy assessments, conducting both pivotal Phase 3 trials and extension studies. Their participation in multicenter international trials reflects their commitment to advancing treatment options for patients with chronic inflammatory diseases. With expertise in both dermatological conditions and gastrointestinal disorders, MaxMed contributes valuable data on comparative effectiveness, non-inferiority studies, and novel mechanism-based therapies targeting immune-mediated conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Usług Medycznych MaxMed
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of 0.1% Mometasone Furoate Cutaneous Emulsion Versus Ecural Fat Cream and Vehicle in Adult Plaque Psoriasis | GALENpharma GmbH | Phase III | Not Recruiting | Oct 2024 | Mar 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apremilast | 1 | Unknown | 2024-05-07 | 2024-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.